The Biden administration cited the “importance of expanding access to testing” in extending free home tests to Medicare recipients
Author: Ken Alltucker, USA TODAY
Free COVID home tests for everyone? Here’s why Medicare, veterans’ insurance are excluded
COVID home tests won’t be covered by Medicare and Tricare, a military insurance program. Some Democrats have asked the federal government to reconsider.
Omicron doesn’t need to ruin the holidays: Here’s what you need to know about rapid tests
Long lines at testing sites and lack of available home tests makes testing challenging for consumers as omicron rages and millions prepare to travel.
As surprise billing ban nears, doctors and hospitals scramble to delay federal law
Hospital and doctors groups want to delay the No Surprises Act’s arbitration rules that they contend unfairly favors insurers and challenges staffing.
With omicron already in California, here’s what US labs are doing to track cases and stop its spread
Public health experts acknowledge the U.S. genomic sequencing efforts of coronavirus lagged behind other nations in the pandemic’s early months.
‘Vast majority are not reported’: Home COVID-19 tests make it impossible to track all cases
Cheap, accessible home tests can uncover more COVID-19 cases. But public health agencies can’t track cases when consumers don’t report them.
‘No cheap, easy or quick fix’: Hospitals oust unvaccinated workers in preview of 50-state mandate
New York hospitals fired workers who refused vaccination. President Biden’s mandate will require nearly all hospital workers to get COVID shots.
Joe Biden’s $2B rapid testing plan calls for discounted COVID tests at Amazon, Kroger and Walmart
President Joe Biden’s plan includes spending nearly $2 billion to procure 280 million rapid coronavirus tests for vulnerable U.S. populations.
America’s fittest city is Arlington, Virginia – for the fourth straight year, study finds
America’s fittest cities report ranks the nation’s 100 most populous cities by 34 measures of personal health, outcomes and community indicators.
Aduhelm, the new $56,000 Alzheimer’s drug, is more expensive than you think. Here’s why.
The new $56,000 Alzheimer’s drug likely will cost more because of tests to verify amyloid beta in patients’ brains and monitoring of brain swelling.